OSL · PHO.OL
Photocure ASA
NOK 46.00-NOK 0.70 (-1.5%)
Photocure ASA’s quoted price sits in the lower half of its reported 52-week range, 42.36% below the high.
Loading market information…
OSL · TRMED.OL · NOK
Stock price, earnings
Quote as of Oct 30, 2026, 08:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · NOK. Historical prices are not a forecast.
Thor Medical ASA’s quoted price sits in the lower half of its reported 52-week range, 41.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Thor Medical ASA’s next earnings report is currently expected on Mar 3, 2027, with estimated earnings per share of -NOK 0.16. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Thor Medical ASA’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2017, Thor Medical ASA, with its headquarters in Oslo, Norway, specializes in the development and provision of alpha-particle emitters for oncology treatments within Norway.
Latest available per-share figures in NOK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:46 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2022 |
|---|
| Mar 31, 2023 |
| -NOK 0.00 |
| NOK 0.00 |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NOK 46.00-NOK 0.70 (-1.5%)
Photocure ASA’s quoted price sits in the lower half of its reported 52-week range, 42.36% below the high.
NOK 3.01-NOK 0.01 (-0.33%)
Nykode Therapeutics AS’s quoted price sits in the lower half of its reported 52-week range, 42.12% below the high.
NOK 21.40NOK 0.00 (0.0%)
ArcticZymes Technologies ASA’s quoted price sits in the lower half of its reported 52-week range, 26.21% below the high.
NOK 38.60-NOK 0.90 (-2.28%)
Gentian Diagnostics AS’s quoted price sits in the lower half of its reported 52-week range, 35.67% below the high.
NOK 7.74+NOK 0.24 (+3.2%)
Lytix Biopharma AS’s quoted price sits in the lower half of its reported 52-week range, 34.96% below the high.
NOK 1.30-NOK 0.01 (-0.38%)
Hofseth BioCare ASA’s quoted price sits in the lower half of its reported 52-week range, 37.14% below the high.
NOK 11.20+NOK 0.20 (+1.82%)
Navamedic ASA’s quoted price sits in the lower half of its reported 52-week range, 57.74% below the high.
NOK 2.28+NOK 0.08 (+3.64%)
Arctic Bioscience AS’s quoted price sits in the lower half of its reported 52-week range, 45.71% below the high.
